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ABSTRACT
Conditional expression of suicide genes in vivo has
a wide range of applications in biological research
and requires a minimal basal promoter activity in
the uninduced state. To reduce basal activity of tetra-
cycline (tc)-inducible target promoters we combined
synthetic tet operators in varying numbers with a
core promoter derived from the plant viral 35S
promoter. An optimized promoter, PTF, was found to
exert a stringent regulation of luciferase in combina-
tion with tTA and rtTA in different mammalian cell
lines. We linked PTF to the barnase gene, coding for a
highly active RNase from Bacillus amyloliquefaciens.
Stable cell clones expressing barnase under control
of tTA exerted cell death only after tc withdrawal,
correlating with a 10-fold induction of barnase mRNA
expression. Directing tTA expression through a
neuron-specific enolase promoter (PNSE) leads to
barnase expression and cell death in neuronal cells
after tc withdrawal. Taken together, our data demon-
strate that a stringent control of barnase expression
in the uninduced state improves cell ablation
studies, as high frequencies of transgene propaga-
tion in both cell lines and in transgenic mice are
observed.
INTRODUCTION
For many applications in gene therapy and medical research,
the expression of a suicide gene at defined time points is of
great advantage. In particular, the cell-specific induction of
toxin genes represents a promising approach for the functional
analysis of distinct cell types in situ. In many human diseases,
loss of distinct cell types leads to detrimental diseases, for
instance in the central nervous system (CNS). Until now,
conditonal cell ablation has been achieved either by introduc-
tion of the herpes simplex thymidine kinase (HSV-tk) cassette
for functional analysis of astrocytes in transgenic mice (1,2) or
by tetracycline (tc)-dependent expression of diphteria toxin A
chain (DTA) in cell lines (3) and transgenic mice (4). These
approaches faced several limitations: the HSV-tk gene is only
applicable to ablation of proliferating cells within the CNS.
Tetracycline controlled expression of DTA led to very low
yields of recombinant cell clones of transgenic mice, as the
original target promotor (5) revealed leakiness in the unin-
duced state.
The tc-dependent expression system is based on a chimeric
transcriptional transactivator tTA, which is a fusion between
the bacterial Tet repressor (TetR) and the constitutive activa-
tion domain of herpes simplex protein 16 (VP16). Binding of
tTA to a target promoter consisting of multiple operators
upstream of a core promoter leads to activation of transcrip-
tion, which can be abrogated by addition of tc or the commonly
used analog doxycycline (dox), which interferes with DNA
binding of tTA. In addition, a TetR mutant that binds DNA
only in the presence of tc has been exploited for the construc-
tion of rtTA, yielding a tc-inducible promoter (6).
In previous reports it has been demonstrated that the effi-
ciency of the tc system is dependent on the cell line tested and
is even more complex in transgenic mice where residual
activity, even in the absence of the transactivator, depends on
the tissue (7,8). The difference in expression levels between
induced and uninduced transgenic tissue is 100 in optimal
cases and varies in different tissues. Residual activity might be
due to transcription factor binding to the CMV core promoter
(7). The problem of leakiness is even more pronounced when
rtTA is used as a transcriptional activator.
Three different approaches have been undertaken to reduce
leakiness of the tc-dependent expression systems. Most
recently, Urlinger et al. (9) isolated new rtTA alleles yielding
lower activation in the uninduced state. Forster et al. (10) and
Imhof et al. (11) used rtTA to drive tc-inducible expression of
a suitable target promoter which was at the same time
repressed by tTA in the absence of tc. This sophisticated
arrangement reduced background activity by a factor of six, but
has the disadvantage of requiring the simultaneous expression of
two trans factors. Hoffmann et al. (12) used a modified mouse
mammary tumor virus promoter (∆MTV) in which the steroid-
responsive elements were replaced by tetO sequences.
However, as access of tTA depends critically on chromatin
(13), induction levels are on average 10-fold lower than in the
CMV based target promoter.
In this work we constructed a new target promoter with
reduced leakiness, by exchanging the viral cytomegalovirus
core promoter by a plant viral promoter and by avoiding
identical spacer sequences between the multimerized opera-
tors. Promoter constructs were tested for basal activity either
with tTA or with rtTA in different mammalian cell lines. As
our major goal is to ablate neuronal cell types within the mouse
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CNS, we included in our analyses cell lines representing the
rodent nervous system. To assess the usefulness of the
optimised promoter in cell ablation experiments, we combined
it with the lethal RNase gene from Bacillus amyloliquefaciens
(barnase; 14), thus demonstrating a stringent cell ablation
strategy for mammalian cells and tissues.
MATERIALS AND METHODS
Plasmids and cloning
The promoters PTAX and PTF were from plasmids pBHTAX and
pBHTF (15). For cloning, the promoter sequences were ampli-
fied by PCR using primers with HindIII linkers. As control
plasmids for tc-dependent luciferase expression, plasmids
pXTC7C53Luc (PXTC-Luc; 5) and pMtetO5Luc (PMtetO5-Luc; 12)
were used. The plasmids pTAX-Luc and pTF-Luc were
obtained by digesting pMtetO5Luc with HindIII, and ligation
of the HindIII promoter fragments into the respective vector
sites. For construction of an expression vector containing the
tc-inducible cDNA for Barnase, PTF was fused to the Barnase
coding region (16). Addition of a mammalian polyadenylation
signal was achieved by cloning it into the expression vector
SBC-1 (17) using ClaI and HindIII. As a regulator plasmid,
we used pUHD15-1 (5) or pUHD17-1 (6) encoding the
tc-dependent transactivator (tTA or rtTA, respectively) under
control of a human cytomegalovirus (hCMV) promotor (PCMV–
tTA or PCMV–rtTA). For cell-specific expression of tTA, the
hCMV promotor was removed by cleaving with XhoI, filled-in
with Klenow DNA Polymerase and digested with EcoRI. A
1.8 kb neuronal-specific enolase (NSE) promotor-fragment
was excised from pCRToPo-cloning vector (Invitrogen,
Heidelberg, Germany) with EcoRI and PvuII and ligated into
unique restriction sites of pUHD15 to construct the neuronal
regulator plasmid PNSE–tTA.
The plasmids pRSVLacZII and pEGFP-N3 (Clontech,
Heidelberg, Germany), containing β-galactosidase cDNA
(lacZ) or GFP under control of constitutive promotors, respec-
tively, were used as reporter plasmids.
Cell culture and transfections
HeLa (ATCC CCL 2), CHOdhfr– (ATCC CRL 9096) hamster
ovary fibroblasts, C6 rat glioma cells (ATCC CCL 107), 293T
human embryonal kidney cells (provided by Dr Jan Cornelis,
DKFZ, Heidelberg, Germany), PC12 rat adrenal pheochromo-
cytoma (ATTC CRL 1721), mouse motoneuron-like cell line
NSC-19 (18), and Neuro-2A neuroblastoma cells (ATCC CCL
153) were maintained in Dulbecco’s modified Eagle medium
(DMEM) containing 10% (v/v) foetal calf serum (FCS;
Biochrom KG, Berlin, Germany); CHOdhfr– cells were
cultured in the presence of Prolin (5 mM) and HT supplement
(0.1 mM hypoxanthin, 0.01 mM thymidine). The cell line
CHOAA8 (Clontech, Heidelberg, Germany), stably expressing
the tc-dependent regulator tTA (plasmid pUHD15-1neo), was
cultured in α-MEM supplemented with 10% FCS and 100 µg/ml
G418 (Gibco BRL). Neuronal cell lines and C6 cells were
transfected with Lipofectamine (Promega, Madison, WI),
CHOdhfr– and 293T cells by using the calcium phosphate
method. The transfection efficiencies were usually >20%, as
determined by control transfections with pEGFP. Depending
on the cell type, 1–3.5 × 105 cells were seeded into 30 mm
plates and constructs were added 24 h later in the absence or
presence of dox (Sigma, Steinheim, Germany). The dishes
with dox were preincubated with 1.0 µg/ml 24 h before trans-
fection. Transient cotransfections were performed with ratios
of 5:1 regulator plasmid to target plasmid (luciferase or
barnase) and cells were analysed 48–72 h after transfection.
Luciferase constructs were stably integrated by electroporating
10 µg PvuI linearised plasmid in a Bio-Rad electroporator with
200 V and 480 µF. For stable transfection of barnase
constructs, cotransfections were done in 1:10 and 1:20 ratios of
pBS∆pac (CHOAA8) or pEGFP-neo (Neuro-2A) to PTF–
barnase. Three days after transfection, transfectants were
selected either with 3.5 µg/ml puromycin or 400 µg/ml G418
(Luciferase plasmids and pEGFP-neo).
Luciferase and β-galactosidase assays
Forty-eight hours after transfection, cells were lysed by the
addition of 150 µl lysis buffer (supplied with the Dual-Light
kit). Activities of β-galactosidase and luciferase were measured
by the Dual-Light Chemieluminescent Reporter Gene Assay
(Tropix, Bedford, MS) using a Lumat LB 9507 (EG&G
Berthold, Bad Wildbad, Germany). Enzyme activities were
adjusted to protein content of cell lysates, which were determi-
nated by the BCA method (Pierce, Rockford, IL).
Quantification of GFP-positive cells
GFP, PTF–barnase and PCMV–tTA (or PNSE–tTA) cotransfected
cells, subsequently cultured in the absence or presence of dox,
were analysed 48 and 72 h after transfection by UV. GFP-positive
cells were counted in similar sections of a number of micro-
scopic fields. Similarly, transfected cells were rinsed from the
plates with 1 ml of phosphate buffered saline (PBS) containing
0.05 mM EDTA. Numbers of GFP-positive cells were deter-
mined in a fluorescence activating cell sorter (FACS; Beckton-
Dickinson) using an argon ion laser at 488 nm excitation wave-
length.
Isolation of RNA and RT–PCR
Total RNAs from cultured cells were isolated by the NucleoSpin
RNA II preparation method (Macherey-Nagel, Düren,
Germany) with an included DNase I digest. Usually, 0.5–1 µg
of total RNA in 20 µl reaction volume was subjected to reverse
transcription (RT) using superscript reverse transcriptase (Life
Technologies GmbH, Eggenstein, Germany). After RT, 2 µl of
a 1:5 dilution was used for PCR amplification in a total volume
of 20 µl, containing MasterMix-Taq (Qiagen, Hilden,
Germany).
For the bacterial RNase barnase the primers were bars (5′-
AGGTCTGATAATGGTCCGT-3′) and baras (5′-AAGGGAA-
CCTGGCAGACGTC-3′); for ribosomal protein L7 mRNA,
L7s (5′-AGATGTACCGCACTGAGATTC-3′) and L7as (5′-
ACTTACCAAGAGACCGAGCAA-3′).
Primers were obtained from TIB MolBiol (Berlin, Germany).
PCR conditions for barnase, 4 min initial denaturation at 94°C,
20–25 cycles with 1 min denaturation at 92°C, 1 min annealing
at 60°C, 45 s elongation at 72°C and finally 10 min extension
at 72°C; for L7 amplification, 4 min initial denaturation at
94°C, 18–22 cycles with 1 min denaturation at 94°C, 45 s
annealing at 62°C, 45 s elongation at 72°C, 10 min extention at
72°C. The resulting amplication products (barnase, 210 bp;
PAGE 3 OF 6 Nucleic Acids Research, 2001, Vol. 29, No. 16 e76
L7, 352 bp) were separated by electrophoresis on 2% agarose
gels and visualised by ethidium bromide staining.
Dot blot analysis
PCR products were diluted by 20× standard saline citrat buffer
(SSC), boiled and transferred via Slot blot (MinifoldRII,
Schleicher & Schuell, Dassel, Germany) to nylon membranes
(Pall Biodyne B, Pall, Dreieich, Germany). The DNA were
fixed by baking. The blots were hybridised with [α-32P]dATP
random labelled PCR amplifications of barnase and L7. After
exposition (Bio-Imager, Bio-Rad, Göttingen, Germany), the
signals were quantified by Bio-Rad Multi-Analyst™ version
1.1.
Documentation
Photodocumentation was done on a Zeiss Axiophot fluores-
cence microscope with phase contrast and UV microscopy.
Images were processed by Adobe Photoshop version 6.0.
RESULTS AND DISCUSSION
Optimisation of a tc-dependent target promoter
In order to reduce the background activity of the target
promoter PXTC (5), two new promoters (both of them
containing multiple tet operator sites upstream of a minimal
promoter) were constructed and fused to luciferase as a
reporter gene. The sequences of both domains of the target
promoter PXTC (5) (the minimal promoter as well as the region
encoding the operators) were altered (Fig. 1). The minimal
promoter, which is in the original PhCMV*-1 the region –53 to
+75 of the hCMV, was exchanged against the region –45 to +1
of the plant viral cauliflower mosaic virus 35S promoter
(15,19). In PTax, the ‘enhancer region’ consists of four opera-
tors and three identical spacer regions, which are different
from those in PhCMV*-1. In PTF the ‘enhancer region’ was
exchanged against a fragment encoding six tet operators. The
difference to PTax is that the sequences between the operators
are not multimerized, but each spacer encodes a different
sequence. The rationale for this alteration is that weak binding
sites between operator sites might lead to background activity
due to synergistic effects. These promoters were tested by tran-
sient transfection assays with tTA and rtTA in different cell
lines and in stable cell clones of CHO cells (Fig. 2). As control
promoters, we used PXTC, the original target promoter
described by Gossen and Bujard, and a mouse mammary tumor
virus (MMTV) LTR derived promoter (PMtetO5), developed as
tc-dependent promoter with reduced basal activity (12).
In all cell lines tested, PTF and PMtetO5 revealed the lowest
basal Luc activities in the uninduced state, which is at least 4–
10-fold depending on the cell line. PTax yielded higher back-
ground activities than PTF, indicating that avoiding the multi-
merisation of identical spacer sequences indeed helps to reduce
background activity. In the induced state, PTF reaches at least
60% of the expression levels of PXTC in cell lines HeLa, CHO,
PC12 and C6. In all these cell lines, PTF activity was higher
than in pMtetO5, this effect being most pronounced in HeLa
cells.
In stable cell clones of CHO cells containing PCMV–tTA and
a single copy integration of respective promoters, the reduction
in basal activity is 12-fold with PTF whereas induction is only
reduced by 25% compared to PXTC. Thus, with this simple
approach, basal activity of the target promoter was drastically
reduced whereas induced activities were only reduced by 50%.
This resulted in an increase of the activation of gene expression
upon withdrawal of tc from 16- to 140-fold. Also, in combina-
tion with rtTA, these promoters yielded lower background
activities in different cell lines, which was between 8- and 12-
fold.
Analysis of conditional barnase expression
The optimised tc-dependent target promoter PTF was used for
conditional suicide gene expression. PTF was fused to the
barnase gene to give PTF–barnase. The barnase gene contains
the coding region for a B.amyloliquefaciens RNase, a small
extracellular RNase protein of 110 amino acid residues, which
is in vivo inhibited by barstar (14). The barnase gene has been
used in transgenic plants for cell-ablation studies (20).
The constructs PTF–barnase, PCMV–tTA (ratio 1:5) and a GFP
(pEGFP) vector were cotransfected and numbers of surviving
cells were determined by counting GFP positive cells (Fig. 3).
Usually, 48–72 h after transfection, cell numbers were reduced
by 80% after tc withdrawal in all cell lines used. The observed
residual cell survival might be due to the lack of simultaneous
presence of all three constructs in one single cell.
Analysis of conditional gene expression in neuronal cells
To assess the regulated expression of barnase in neuronal
cells, we generated stable Neuro2A cell clones comprising a
low copy number of PTF–barnase integrates. We received
barnase positive Neuro2A clones (70% of all G418 resistant
cell clones) that survived the selection procedure and exerted a
conditional barnase expression after transient transfection
with PCMV–tTA, PCMV–rtTA, PNSE–tTA (Fig. 4), which led to
cell reduction of at least 70% after 48 h. As a comparable
induction rate would be achieved with a number of weak, cell-
specific promoters, demonstrated by the neuronal-specific
enolase (PNSE) promoter, we argue that even a low induction of
the barnase gene in vivo is sufficient to ablate specific cell
types in transgenic mice.
To analyse the kinetics of conditional barnase expression,
we generated individual CHO-AA8 (contains a stable integrate
of PCMV–tTA) cell clones containing stable integrates of PTF-
barnase. Out of 12 CHO cell clones positive for barnase,
Figure 1. Target promoter constructions (PXTC, PMtetO5, PTAX, PTF) linked to
luciferase or barnase used for analyses. Transcription start sites are indicated
by arrows. Note that in PTF, the spacer sequences between tet operators differ
from each other.
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seven cell cones survived for a longer time period and barnase
expression was tc-inducible. From this calculation, >60% of all
cell clones obtained revealed conditional cell ablation by the
barnase gene. A representative induction experiment with a
double-stable CHO cell clone is shown in Figure 5. The
mRNA levels of barnase were determined by semiquantitative
RT–PCR (Fig. 5A). Induction of barnase is maximal 7 days
after tc withdrawal and drops to lower levels later on (Fig. 5C).
At this time point, cell morphology appeared normal whereas 9
days after tc withdrawal, a clear-cut change in cell morphology
was detectable (Fig. 5B and C). and no cell showed normal
morphology compared to the uninduced state, demonstrating a
complete cell ablation. The reason for the delayed kinetics of
Barnase accumulation or toxicity compared to maximal levels
of mRNA induction is unknown. However, a similar kinetic of
luciferase accumulation has been observed with this promoter
in transgenic plants (19). Similar ablation results were obtained
with irradiated CHO cells. These cells were also completely
ablated 11 days after tc withdrawal demonstrating that even
Figure 2. Comparative transactivation measurements of promoter–luciferase constructs in cell lines HeLa, HEK293, CHO, PC12 and C6 cells with either rtTA or
tTA, with (+) dox (1 µg/ml) or without (–) dox. Mean values of five independent experiments 48 h after transient transfection of 100 ng target promoter construct
and 500 ng PCMV-rtTA or PCMV-tTA. The mean values of promoter activity from six different CHOAA8 (PCMV-tTA) cell clones comprising low copy integrations of
promoter–luciferase constructs in the uninduced state and 48 h after dox withdrawal are shown to the right.
Figure 3. Tetracycline-induced cell ablation by barnase in cell lines CHO,
PC12, C6 and HEK with the PTF–barnase construct. Cells were cotransfected
with PTF–barnase (100 ng), PCMV–tTA (500 ng) and with 100 ng pEGFP with
(+) or without (–) dox; 48 h after transfection, cell numbers were determined
as mean values by counting GFP+ cells in 10 independent fields of vision under
the UV microscope (magnification 100×). Right diagram, for comparison, the
number of HEK cells transfected as above were determined by FACS analysis.
Figure 4. Tetracycline-dependent ablation of two stable barnase containing
Neuro2A cell clones by PCMV–rtTA, PCMV–tTA and PNSE–tTA. Neuro2A clones
A1 and D3 were transfected with 500 ng of regulator construct. 48 h after
transfection either in the presence (+dox) or in the absence (–dox) of inducer,
cell numbers were determined by counting 10 independent fields of vision.
Cells transfected with the regulator constructs in the uninduced state (+ for
tTA; – for rtTA) were taken as 100% control by definition.
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under non-proliferative conditions, Barnase can act as suicide
gene (data not shown).
We also injected the PTF–barnase construct in pronuclei to
generate transgenic mice. So far, similar to the observations in
cell lines, we obtained high frequencies of barnase positive
offsprings: from 10 born mice, 2 founder mice aroused, which
were viable and had a normal phenotype. These results imply
that conditional barnase expression with PTF resulted in higher
frequencies of viable littermates as observed with a PXTC–DTA
construct, for which an ∼1% rate of viable offsprings (3 per
317 born offsprings; 4) was obtained.
In conclusion, we have presented a conditional suicide
system based on a modified tc-dependent expression system
and combined it with a prokaryotic RNase. We found that the
low basal activity of PTF allows a high percentage of transgenic
propagation in cell lines and mice. In combination with
barnase, even low induction levels of the target promoter,
usually achieved by tTA expression under cell-specific
promoters, are sufficient to exert conditional cell ablation.
Thus, our novel cell ablation strategy might have an impact on
the molecular analysis of pathological processes in transgenic
animals, in particular in the CNS.
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